Search Within

Heather Jolie Landau

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
Groups
  1. Bone Marrow Transplant (8)
  2. Center for Hematologic Malignancies (8)
  3. Center for Molecular Imaging and Biotechnology (8)
  4. Department of Medicine (8)
  5. GSK Faculty (8)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Alexander Lesokhin (5)
  2. David Chung (5)
  3. Sergio Giralt (5)
  4. Karuna Ganesh (4)
  5. Caleb Ho (3)
  6. Elli Papaemmanuil (3)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2020 (2)
  4. 2017 (1)
  5. 2014 (1)
  6. 2013 (1)
Publications
  1. Blood (4)
  2. Biology of Blood and Marrow Transplantation (1)
  3. Cancer Research (1)
  4. Journal of Clinical Investigation (1)
  5. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Hematology (4)
  2. American Association for Cancer Research (1)
  3. American Society for Clinical Investigation (1)
  4. Elsevier Inc. (1)
  5. Taylor & Francis Group (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Chemotherapy-related mutational signatures reveal the origins of therapy-related myeloid neoplasms
    Meeting Abstract

    Diamond, B.; Ziccheddu, B.; Boyle, E. M.; Maclachlan, K.; Taylor, J.; Watts, J. M.; Lu, S. X.; Coffey, D. G.; Bolli, N.; Papaemmanuil, E.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Meeting Abstract

    Ziccheddu, B.; Diamond, B.; Maclachlan, K. H.; Taylor, J.; Boyle, E. M.; Arango Ossa, J. E.; Jacob, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Presalvage international staging system stage and other important outcome associations in CD34(+)-selected allogeneic hematopoietic stem cell transplantation for multiple myelomas
    Journal Article

    Bryant, A. R.; Hilden, P.; Giralt, S.; Chung, D. J.; Maloy, M.; Landau, H.; Landgren, O.; Scordo, M.; Shah, G.; Smith, E. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Gain of chromosome 1q portends worse prognosis in multiple myeloma despite novel agent-based induction regimens and autologous transplantation
    Journal Article

    Shah, G. L.; Landau, H.; Londono, D.; Devlin, S. M.; Kosuri, S.; Lesokhin, A. M.; Lendvai, N.; Hassoun, H.; Chung, D. J.; Koehne, G.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
    Meeting Abstract

    Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma
    Meeting Abstract

    Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
    Blood (2013)

    Fulltext@MSK | Save